reports
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region ...
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share in Middle East & Africa, led by strong performance in Algeria with the FIAT Professional brand Confirms market leadership in Europe 30 and South AmericaNorth America plays a key role in Pro One success; Ram announces new professional commercial vehicle divi...
AMG Reports Financial and Operating Results for the First Quarter of 2...
AMG Reports Financial and Operating Results for the First Quarter of 2024 Company reports EPS of $4.14, Economic EPS of $5.37 in first quarter Net Income (controlling interest) of $150 million, Economic Net Income (controlling interest) of $187 millionEconomic Earnings per share increased 28% year-over-year, reflecting strong business momentum and the positive impact of our capital allocation strategyIssued $450 million of 40-year junior hybrid debt and repurchased approximately $150 million in common stock WEST PALM BEACH, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AMG, a leading partner t...
Sanergy Group Limited: 1 director
A director at Sanergy Group Limited sold 78,000,000 shares at 2.580HKD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Anton Oilfield Services Group: 1 director
A director at Anton Oilfield Services Group sold 1,125,000 shares at 0.426HKD and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Hi...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data demonstrating potential of a MYC-targeting epigenomic controller in NSCLC at AACR 2024Company to present new preclinical data demonstrating durable epigenomic upregulation and other OMEGA platform capabilities at ASGCT 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- O...
WisdomTree Sends Letter to Stockholders Urging Full Support of the Cur...
NEW YORK--(BUSINESS WIRE)-- The Board of Directors of WisdomTree, Inc. (NYSE: WT), a global financial innovator, today issued a letter urging its stockholders to protect their investment by voting “FOR” all of WisdomTree’s highly qualified director nominees at the upcoming 2024 Annual Meeting of Stockholders on June 12, 2024. WisdomTree has demonstrated strong momentum with its current strategy and is in a pivotal phase of execution and growth. Our Board oversees the management team in developing and shaping that strategy, a relationship that has benefitted greatly from the Board’s mix of de...
Signify share repurchase periodic update
Signify share repurchase periodic update Press Release May 6, 2024 Signify share repurchase periodic update Eindhoven, The Netherlands – (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 153,980 shares in the period April 29 to May 3, 2024. The shares were repurchased at an average price of EUR 25.70 per share and an aggregate amount of EUR 4.0 million. These repurchases were made as part of the company’s repurchase program, which was announced on April 29, 2024. Signify will use the shares to cover obligations arising from its long-term incentiv...
Verkkokauppa.com Oyj: Jesper Blomster appointed as new CFO and member ...
Verkkokauppa.com Oyj: Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj Verkkokauppa.com Oyj STOCK EXCHANGE RELEASE 6 May 2024 at 2.00 p.m. EEST Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj MSc. (econ) Jesper Blomster (37) has been appointed as Chief Financial Officer (CFO) and a member of the management team in Verkkokauppa.com Oyj as of May 7, 2024. Blomster joins Verkkokauppa.com from Fiskars, where he has worked as SVP Finance and in other finance positions. Before Fiskars, he held va...
Neumora Therapeutics to Participate in Upcoming Conferences in May
Neumora Therapeutics to Participate in Upcoming Conferences in May WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that the Company will participate in two investor conferences in May: BofA Securities Healthcare Conference 2024: Members of management will participate in a fireside chat on Tuesday, May 14, 2024, at 1:00 PM ET (10:00 AM PT) in Las Vegas, NV.2024 RBC Capital Markets Global ...
Métaux Osisko annonce la mise à jour de l'estimation des ressources mi...
Métaux Osisko annonce la mise à jour de l'estimation des ressources minérales à Mine Gaspé - ressources indiquées de 495 Mt à une teneur de 0,37% en équivalence de cuivre MONTRÉAL, 06 mai 2024 (GLOBE NEWSWIRE) -- Métaux Osisko Incorporée (la « Société » ou « Métaux Osisko ») (; ; ) a le plaisir d'annoncer une mise à jour de l'estimation des ressources minérales ( « ERM ») au Mont Copper dans le cadre du projet de cuivre de Mines Gaspé, situé près de Murdochville dans la péninsule gaspésienne du Québec. L'ERM mise à jour (voir le tableau 1 ci-dessous) comprend des ressources indiquées, au...
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA...
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Proliferative Diabetic Retinopathy – DURAVYU demonstrates stable or improved disease severity with reduced rates of NPDR progression at nine months – – DURAVYU continues to demonstrate favorable safety and tolerability profile with no drug-related serious adverse events – – Conference call to discuss the results to be held at 8:00 a.m. ET – WATERTOWN, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing ...
Axsome Therapeutics Reports First Quarter 2024 Financial Results and P...
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi® 1Q 2024 net product revenue of $21.6 million representing 64% year-over-year growth Contract executed with second large group purchasing organization (GPO) for potential coverage of Auvelity Positive pivotal Phase 3 trial results of AXS-12 in narcolepsy announced Topline results of ADVANCE-2 Phase 3 tr...
Agios to Present at the BofA Securities 2024 Health Care Conference on...
Agios to Present at the BofA Securities 2024 Health Care Conference on May 16, 2024 CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company is scheduled to present at the BofA Securities 2024 Health Care Conference on Thursday, May 16, 2024, at 11:40 a.m. ET. A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at . A replay of the webcast will be arc...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on ...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will report first quarter 2024 financial results on Monday, May 13, 2024, after the U.S. markets close. The press release will be available under “Press Releases” in the Investors section of the Company’s website at . About Cara Therapeutics Cara Therapeu...
BioCryst Reports First Quarter 2024 Financial Results and Provides Bus...
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update —Q1 2024 ORLADEYO net revenue grows 30 percent y-o-y to $88.9 million— —Full-year 2024 ORLADEYO revenue guidance adjusted to $390-$400 million (top end of prior guidance range) — —Pipeline programs, including BCX17725 for Netherton syndrome and avoralstat for DME, advancing on schedule into clinical trials— RESEARCH TRIANGLE PARK, N.C., May 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq:BCRX) today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update. “We are off...
Brookfield Asset Management and Castlelake to Enter into Strategic Par...
Brookfield Asset Management and Castlelake to Enter into Strategic Partnership Brookfield to acquire 51% interest in Castlelake’s fee-related earnings and invest in the firm’s funds and strategies, total capital amounting to $1.5B BROOKFIELD NEWS, May 06, 2024 (GLOBE NEWSWIRE) -- Brookfield Asset Management (NYSE: BAM, TSX: BAM) (“Brookfield”) and Castlelake L.P. (“Castlelake”), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have entered into an agreement whereby Brookfield will acquire a 51% s...
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerati...
LOBO EV Reports Fiscal Year 2023 Results and Sets Stage for Accelerating Growth in 2024 Net profit margin increased to 6.4% in 2023, up from 6.1% in 2022 Capital from IPO driving new customer acquisitions and production capacity expansion International expansion and innovative product launches position LOBO for growth in 2024 WUXI, China, May 06, 2024 (GLOBE NEWSWIRE) -- LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric vehicle manufacturer and seller, today announced its financial results for the fiscal year ended December 31, 2023....
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America...
Apellis Pharmaceuticals to Host a Fireside Chat at the Bank of America Securities Healthcare Conference WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the Bank of America Securities Healthcare Conference on Tuesday, May 14, 2024, at 8:00 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s . A replay of the webcast will be available for approximately 90 days following the event. About Apel...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and ...
Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report first quarter 2024 financial and operating results after market close on Monday, May 13, 2024. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET to review its financial and operating results. To participate via telephone and join the call live, please register in advance here: . Upon reg...
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on Ma...
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9 SHOHAM, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a webinar on May 9, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Mobilicom Founder and CEO Oren Elkayam, who will share insight into the Company’s recent successes and near-term growth initiatives. A live Q&A session with Elkayam will follow the presentation. To register for ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.